Jin Gao
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
HEY1-mediated cisplatin resistance in lung adenocarcinoma via epithelial-mesenchymal transition.
Journal: Medical oncology (Northwood, London, England)
Published: July 21, 2022
CMTM3 as a Potential New Immune Checkpoint Regulator.
Journal: Journal of oncology
Published: May 09, 2022
Long noncoding RNA SNHG17: a novel molecule in human cancers.
Journal: Cancer cell international
Published: November 06, 2021
Retraction Note to: Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation.
Journal: Cancer cell international
Published: January 12, 2021
LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma.
Journal: OncoTargets and therapy
Published: January 06, 2020
Inhibition of ZEB1-AS1 confers cisplatin sensitivity in breast cancer by promoting microRNA-129-5p-dependent ZEB1 downregulation.
Journal: Cancer cell international
Published: February 02, 2019
MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
Journal: Journal of cellular physiology
Published: March 18, 2018
MiR-133a Is Functionally Involved in Doxorubicin-Resistance in Breast Cancer Cells MCF-7 via Its Regulation of the Expression of Uncoupling Protein 2.
Journal: PloS one
Published: September 24, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026